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Abstract
Background
We conducted a pilot test of American Cancer Society 
Workplace Solutions, an intervention that takes a mar-
keting  approach  to  increasing  employers’  adoption  of 
evidence-based  practices  to  prevent  and  control  chronic 
diseases among their employees.
Context
We delivered the intervention and assessed the changes 
in practices of 8 large employers in the Pacific Northwest.
Methods
Workplace Solutions recommends 15 employer practices 
in 5 categories: 1) health insurance benefits, 2) policies, 
3)  workplace  programs,  4)  health-promoting  communi-
cation, and 5) tracking of employee health behaviors to 
measure  progress.  The  intervention  includes  4  meet-
ings  with  employers  over  2  months  and  begins  with  a 
questionnaire-based  assessment  of  employer  practices. 
Tailored recommendations follow, along with practice-spe-
cific implementation assistance on requested topics. We 
tested the intervention in a before–after study without a 
comparison group.
Consequences
The  employers  ranged  in  size  from  7500  to  115,522 
employees  and  included  private  companies  and  public 
employers.  Seven  of  the  eight  employers  implemented 
more of the recommended practices at follow-up (an aver-
age of 13 months after the intervention) than at baseline. 
Overall, implementation of the practices increased from 
38% at baseline to 61% at follow-up (P = .02).
Interpretation
Workplace  Solutions  is  a  promising  new  approach  to 
bringing  evidence-based  best  practices  for  preventing 
chronic disease to large numbers of adults.
Background
Employers are important community partners for pre-
venting chronic diseases for 3 reasons. First, they have 
power over workplace environments that affect the lives 
of working-age adults, most of whom are in the workplace 
most days of the week (1). Second, employers face rapidly 
mounting health care and productivity costs attributable to 
chronic diseases experienced by their employees — many 
of whom are from the baby-boom generation and are now 
advancing through middle age (2) — and have increas-
ingly strong motivation to promote preventive practices 
aimed at these diseases. Third, employers control health-
insurance coverage of preventive care for 59% of working 
adults and their dependents (3). Recent research shows 
that employers do a poor job of covering evidence-based 
preventive care. For example, less than 10% of employers 
of any size offer optimal coverage for smoking cessation 
treatment (4).
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For  information  about  preventing  chronic  diseases 
among their employees, employers can draw on systematic 
reviews and recommendations from 4 expert groups: 1) 
the U.S. Preventive Services Task Force (USPSTF), 2) the 
Advisory Committee on Immunization Practices (ACIP), 
3)  the  Task  Force  on  Community  Preventive  Services 
(TFCPS),  and  4)  the  Partnership  for  Prevention  (PFP). 
The  USPSTF  and  the  ACIP  review  the  effectiveness  of 
clinical preventive care (5,6). The TFCPS and its Guide to 
Community  Preventive  Services  review  the  effectiveness 
of  policies,  systems  approaches,  and  community-based 
(including workplace-based) programs (7). The PFP builds 
upon the work of the USPSTF and the ACIP by prioritiz-
ing effective clinical preventive care services on the basis 
of cost-effectiveness and their impact on health (8).
Identifying and recommending best practices in health 
insurance benefits and workplace policies and programs 
for employers is the first step; increasing the adoption of 
these practices by employers is the essential next step. To 
ensure adoption, Maibach et al suggest using a market-
ing approach with 3 components: 1) conducting consumer 
research, 2) building sustainable distribution channels, and 
3) improving products and product selection and reducing 
product price (9). Our research among workplace-related 
“consumers”  has  found  that  large  employers  and  their 
human resources staff are important targets both because 
of the substantial number of people they employ and their 
potential to change norms regarding insurance coverage 
for preventive care (10). Our sustainable distribution chan-
nel is a large, voluntary public health organization, the 
American Cancer Society (ACS), which has long-standing 
relationships with employers, thousands of staff through-
out all 50 states, and one of the best-recognized “brands” 
for health in the country. We followed Maibach’s recom-
mendation for improving products and product selection 
and for reducing product price in 3 ways. First, we selected 
a set of employer best practices that are evidence-based 
and focused on creating a supportive workplace environ-
ment for prevention. Second, we tailored the product to the 
needs and current practices of each employer. Third, we 
presented our information in face-to-face sessions in the 
workplace, emphasized the business case for cost-effective 
prevention,  and  provided  implementation  assistance  to 
ease adoption for employers.
We present here the results of a pilot test of Workplace 
Solutions,  a  marketing  approach  to  increase  employers’ 
adoption of evidence-based practices to prevent and con-
trol chronic diseases among their employees. Our purpose 
in conducting the pilot test was to assess the feasibility of 
our approach and to test whether employers adopted the 
recommended practices.
Context
We conducted the study as a joint project of the ACS 
Great West Division, 1 of 13 geographic divisions of the 
ACS, and the University of Washington Health Promotion 
Research  Center  (HPRC),  1  of  33  Prevention  Research 
Centers  supported  by  the  Centers  for  Disease  Control 
and Prevention (CDC). ACS staff approached employers 
with whom they had established fundraising relationships 
about participating in this new workplace health promo-
tion project. Employers were eligible if they had more than 
5000  employees  and  headquarters  in  Idaho,  Oregon,  or 
Washington.
Methods
Selection of best practices
To select which best practices to include in our interven-
tion, we reviewed the recommendations of the USPSTF, 
ACIP,  and  TFCPS  for  interventions  applicable  to  the 
workplace, working-age adults, and prevention of cancer 
and  other  chronic  diseases.  We  included  best  practices 
applicable to the workplace even if they had not been eval-
uated in the workplace. Our review produced a set of 15 
best practices that we categorized into 5 functional groups: 
1) insurance benefits, 2) workplace policies, 3) workplace 
programs, 4) tracking, and 5) communication (Table 1). 
Of the 15 best practices, 10 relate to creating a supportive 
environment for prevention.
Intervention design
We  tested  the  intervention  in  a  before–after  study 
without a comparison group. Our intervention consisted 
of  4  face-to-face  meetings  with  each  employer  during  2 
months.  Our  intervention  team  consisted  of  ACS  staff 
accompanied by 1 or 2 members of the HPRC (J.R.H. and 
J.C.). We met with the employers’ human resources staff 
in charge of purchasing health insurance benefits at each 
employer’s headquarters. At the first recruitment meet-
ing, we presented our general approach and emphasized 
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for employers and employees. At the second meeting, we 
measured  the  employers’  baseline  practices.  After  the 
second meeting, we wrote a 5- to 8-page report of recom-
mendations for improving all practices that the baseline 
survey indicated were not fully implemented. At the third 
meeting,  we  presented  the  recommendations,  discussed 
the potential for adoption of best practices, and asked the 
employers to choose 3 to 5 practices for adoption from the 
recommendations.  At  the  fourth  meeting,  we  presented 
Solution Sets for the practices employers selected. Solution 
Sets consisted of 1 to 3 pages of implementation-oriented 
text (i.e., a summary of evidence detailing why the practice 
should be adopted and information about how to imple-
ment the practice) and other supporting materials, cost 
calculators that estimated first-year implementation costs 
and return on investment, lists of vendors that could assist 
with the recommended practice, and information on rel-
evant programs or materials available from the ACS (11).
Our  intervention  materials  emphasized  the  business 
case for prevention of chronic diseases. For example, we 
highlighted that the PFP review rated 3 of the 5 clinical 
preventive  services  we  recommended  as  either  cost-sav-
ing (e.g., tobacco cessation treatment) or cost-neutral (e.g., 
colon cancer screening, influenza vaccination) (Table 1) (8) 
and that other analyses show that providing tobacco-cessa-
tion treatment and influenza vaccination to employees is 
usually cost-saving, particularly when productivity gains 
are counted (12,13).
The  institutional  review  board  of  the  University  of 
Washington  reviewed  the  study  and  classified  it  as 
exempt.
Study measurements
Employers completed 3 questionnaires during the inter-
vention period: 2 at baseline and 1 after the intervention. 
At baseline, each employer completed a pre-assessment 
survey of employer characteristics, employee demograph-
ics, and employers’ insurance providers. Employers also 
completed a baseline survey of best practices, a compre-
hensive survey of the employers’ health-related practices 
adapted from Golaszewski et al (14). The questionnaire 
included  115  items;  36  measured  the  15  best  practices 
that we included in our analyses. For follow-up at 1 year, 
we developed a streamlined version of the baseline survey 
and included only the questions relevant to the 15 best 
practices and a few items measuring employer satisfaction 
with the intervention.
We scored employers on their responses to the questions 
related  to  each  best  practice.  For  questions  concerning 
benefit coverage and tobacco-use restrictions, we used 3 
possible scores: 1) a score of 0 if the practice was not in 
place at all, 2) a score of .75 if the practice was partially 
in place (i.e., covered with co-pay for benefits or smoking 
forbidden indoors), and 3) a score of 1 if the practice was 
fully in place (i.e., coverage with no co-pay for benefits or 
a campus-wide ban on tobacco use). We used a score of .75 
(rather than .50) for practices partially in place to reflect 
the fact that, by covering most of the costs associated with 
cancer screening and smoking cessation medications or by 
forbidding  smoking  indoors,  employers  are  significantly 
aiding  employees’  health.  For  all  other  questions,  we 
scored dichotomously, using a score of 1 for a practice that 
was in place and a score of 0 for a practice that was not in 
place. For each best practice, we created a summary score 
by summing the items measuring the practice and divid-
ing by the number of items. Thus, we scored each best 
practice as being implemented from 0% to 100%. For each 
employer, we calculated an overall best practice score by 
summing the scores on the individual best practices and 
taking the mean.
Data analysis
Because  the  number  of  participating  employers  was 
small, we conducted primarily descriptive analyses. We 
calculated mean scores and 95% confidence intervals at 
baseline and follow-up, and mean change in score for 1) 
each best practice and 2) the total of all 15 best practices. 
Because  of  the  small  sample  size  and  non-normal  dis-
tribution of the data, we assessed the significance of the 
median change in scores with nonparametric sign tests. 
We present mean scores for ease of interpretation, but all 
presented P values (α = .05) are from these sign tests of 
median change. We also examined change in baseline and 
follow-up scores separately for practices for which employ-
ers did or did not receive Solution Sets.
Consequences
Participating employers
Of the 10 employers we approached, 9 agreed to partici-
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pate in the intervention and completed the baseline sur-
veys. One company later became ineligible to participate 
because it was purchased by another company, so the final 
sample was 8 employers. We followed employers for an 
average of 13 months (range, 8–18 months) from baseline 
to follow-up assessment. Employers ranged in size from 
7500 to 115,522 employees (median, 12,695; mean, 33,104; 
SD, 37,408), and represented various industries (Table 2).
Baseline implementation of best practices
The employers’ total baseline best practice scores ranged 
from 23% to 58% (Table 2), with a mean of 38% (Table 3). 
Employers varied considerably among practices at base-
line; they were most likely to cover cancer screenings (78%) 
and impose smoking restrictions or bans (72%) (Table 3). 
No employers had sun-protection policies, required insur-
ance providers to track delivery of preventive services, or 
gave reminders for preventive services.
Follow-up implementation of best practices
Seven of eight employers improved their total best prac-
tice scores from baseline to follow-up (Table 2). Scores at 
follow-up ranged from 37% to 85% (Table 2), with a mean 
follow-up  score  of  61%  (Table  3),  a  significant  increase 
from  baseline  (P  =  .02).  Employers  achieved  significant 
improvement from baseline to follow-up in the areas of 
covering tobacco cessation treatment (31% mean change, P 
= .03) and covering cancer screening (18% mean change, P 
= .03) (Table 3). The lowest mean change occurred for pro-
viding sun protection (0%) and providing physical activity 
facilities (8%).
Our duration of follow-up varied from 8 to 18 months, 
and  benefit–design  cycles  for  employers  are  often  12 
months  long;  however,  we  found  little  difference  in  the 
change in practices for the 6 employers with at least 12 
months of follow-up (25% change) and the 2 employers 
with fewer than 12 months of follow-up (20% change).
Impact of Solution Sets
Employers’ baseline scores were lower for practices for 
which  they  received  Solution  Sets  (31%)  than  for  prac-
tices for which they did not receive Solution Sets (41%), 
yet the follow-up scores for both groups of practices were 
essentially the same (63% for those given Solution Sets, 
60% for those not given Solution Sets). Thus, employers’ 
scores improved 32% for practices with Solution Sets (P = 
.02) compared with 19% for practices with no Solution Sets 
(P = .45) (data not shown). Employers were most likely to 
request Solution Sets for covering tobacco cessation treat-
ment (n = 7) and for covering cancer screening (n = 7).
Feedback from employers
Employers were generally positive in their ratings of the 
intervention. Seven of the eight employers would recom-
mend the intervention to other companies, and 5 employ-
ers intended to participate in additional programs offered 
by ACS.
Interpretation
Workplace Solutions was associated with a large and 
significant increase in implementation of evidence-based 
best  practices  aimed  at  prevention  of  cancer  and  other 
chronic  diseases  by  large  employers.  At  baseline,  only 
38% of our recommended practices were in place, so there 
was substantial room for improvement. At follow-up, 61% 
of recommended practices were in place. Seven of eight 
employers  improved  their  implementation  of  best  prac-
tices after the intervention.
Of the 15 prevention practices we addressed, 2 (covering 
tobacco cessation treatment and covering cancer screen-
ing) improved significantly. From these results, we specu-
late that employers find it easiest to change practices that 
can be outsourced, such as health insurance coverage, but 
we need to test larger numbers of employers to be certain. 
The large employers in our study were all self-insured, 
and  changing  health  insurance  coverage  may  be  more 
difficult  for  midsized  and  small  employers  that  are  not 
self-insured.
We  found  a  large  change  among  best  practices  for 
which  we  provided  implementation-oriented  assistance 
via Solution Sets. Furthermore, we found that employers 
were more likely to request this assistance for practices 
on  which  they  scored  poorly  at  baseline.  These  results 
suggest that more intensive intervention may have been 
associated with greater effect. Alternatively, the request 
for a Solution Set could have represented an intention by 
the employer to adopt the practice.
Our  more  subjective  assessment  of  contributors  and 
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appropriateness  of  our  focus  on  chronic  diseases  could 
have been an issue for the one employer who made no 
change  in  response  to  the  intervention.  This  employer 
had a much younger employee population than the other 
employers in our study. Second, the opportunity to work 
with  high-ranking  human-resources  staff  appeared  to 
affect  adoption  of  recommended  practices  positively. 
Third,  our  2  government  employers  had  relatively  low 
rates of adoption of recommended practices, which may 
be  caused  by  the  long  decision  chain  within  unionized 
governmental bureaucracies.
The change in tobacco-related practices merits special 
mention. Like other researchers, we found that employer 
coverage of tobacco cessation treatment was low at base-
line  (4).  Tobacco  cessation  treatment  remains  a  missed 
opportunity for employers, because it is cost-saving and 
valuable to smoking employees. Unfortunately, it is not 
provided by most employers.
The limitations of this pilot study include its small sam-
ple, its design, and our focus on employer practices rather 
than employee behaviors. Our small pilot study included 
only  8  employers.  Nonetheless,  our  intervention  was 
associated with a meaningful and statistically significant 
change in the implementation of recommended practices.
Our  study  design,  before–after  without  comparison, 
raises the possibility of historical effects, socially desirable 
responses, and interviewer bias. Changes of this magni-
tude during this short period seem likely to be due to the 
intervention rather than to historical effects. The objec-
tive nature of the practices we measured makes report 
of better practices because of social desirability unlikely. 
Interviewer  bias  is  possible,  because  the  intervention 
team measured implementation of practices both before 
and after the intervention. However, during interviewer 
training, we emphasized a consistent approach to mea-
surement.
Our  focus  on  employer  practices  and  not  employee 
behaviors was another limitation. Our best practices were 
recommended by the USPSTF or the TFCPS because they 
are effective in increasing healthy behaviors. We can rea-
sonably expect that employees will improve the behaviors 
targeted by the intervention practices, but this remains to 
be proven.
We  have  developed  and  pilot-tested  a  marketing-ori-
ented  approach  to  improving  large  employers’  practices 
for  preventing  chronic  diseases  among  their  employees. 
The behaviors we targeted are tied to the leading causes 
of death in the United States (15). The practices we tar-
geted  have  a  strong  evidence  base  and  rank  highly  on 
effectiveness and cost-effectiveness (8). Strengths of our 
marketing-oriented approach include its focus on employ-
ers’ need to control health-related costs and its emphasis 
on environmental approaches to behavior change.
How  generalizable  is  a  resource-intensive  interven-
tion like ours to midsized and small-sized employers? In 
Washington, a state of average population size, there are 
approximately 206,000 employers (10). Approximately 200 
large employers (i.e., those with more than 1000 employ-
ees)  employ  18%  of  the  workforce,  and  3500  midsized 
employers (i.e., with 100 to 999 employees) employ 30% 
of the workforce. Approximately 202,000 small employers 
(i.e., with 99 or fewer employees) employ the remaining 
52% of the workforce. Working with a partner like the 
ACS,  reaching  large  and  midsized  companies  with  this 
type of an intervention or a streamlined version we are 
now testing in partnership with the ACS, might be fea-
sible. However, for small employers we need to consider 
other broad-reach approaches, such as an interactive tool 
on  the  Web,  or  work  through  powerful  intermediaries, 
such as health insurance brokers.
In the future, we plan to confirm the results of this pilot 
study with a larger employer sample and a more robust 
study design. Future studies should test the effects of the 
intervention on employee behaviors, employee productiv-
ity, and employer health care costs.
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Table 1. Employers’ Best Practices for Preventing Chronic Diseases, by Practice Type, 8 Pacific Northwest Employers, 
American Cancer Society Workplace Solutions Pilot Study, 2005–2006
Practice Type Best Practice
Relevant Community Guide 
Recommendation(s)a
Relevant USPSTF 
Recommendation(s) and Prevention 
Prioritiesa 
[CPB/CE/Total Scoresb]
Insurance Benefits . Provide full coverage for tobacco ces-
sation treatments, including prescription 
medications, over-the-counter nicotine 
replacement therapy, and counseling.
Reduce out-of-pocket costs for tobacco-
cessation programs
Tobacco-use screening and cessation 
intervention [5/5/0]
2. Provide full coverage for breast, cervi-
cal, and colon cancer screenings.
Reduce out-of-pocket costs for breast 
cancer screening
Breast: mammography [/2/] 
Cervical: Pap smear [/3/7] 
Colorectal: any of  tests [//8]
3. Provide full coverage for influenza vac-
cination.
Reduce out-of-pocket costs for vaccina-
tions
Annual vaccination for adults aged 50 
and older [//8]
. Require health plans to send remind-
ers to members and network providers 
about preventive health services.
Client and provider reminders for breast, 
cervical, and colon cancer screening and 
influenza vaccination
 
5. Require health plans to track delivery 
of preventive health services and send 
performance feedback to network provid-
ers.
Assess providers’ delivery of recom-
mended cancer screenings and influenza 
vaccination and give feedback
 
Workplace Policies . Ban tobacco use at worksites. Smoking bans and restrictions (to reduce 
environmental smoke)
 
7. Post ““Use the Stairs” reminder signs 
near elevators.
Point-of-decision prompts to increase 
physical activity
 
8. Provide facilities for physical activity. Enhance access to physical activity facili-
ties in combination with informational 
outreach
 
9. Make healthy food choices available 
and affordable.
Multicomponent interventions aimed 
at diet, physical activity, and cognitive 
change
 
0. Require and provide sun protection 
for employees who work outdoors.
Insufficient evidence for occupational 
settings, but recommended for adults in 
recreational settings
Currently under review by USPSTF
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USPSTF indicates United States Preventive Services Task Force; CPB, clinically preventable burden; CE, cost effectiveness; NA, not applicable. 
a Summary of recommendations from the USPSTF (5) and the Community Guide (7), as well as health impact and cost-effectiveness scores from the 
Prevention Priorities (9). 
b Possible scores for both CPB and CE range from  to 5, with 5 indicating greatest value. Scores in this column as cited in Maciosek et al (8). Empty cells 
in this column indicate practices that are not recommended by ACIP or USPSTF. 
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Practice Type Best Practice
Relevant Community Guide 
Recommendation(s)a
Relevant USPSTF 
Recommendation(s) and Prevention 
Prioritiesa 
[CPB/CE/Total Scoresb]
Workplace 
Programs
. Sponsor a tobacco cessation quit-
line, including nicotine replacement 
therapy.
Multicomponent interventions that 
include client telephone support to 
increase tobacco cessation
Tobacco-use screening and cessation 
intervention [5/5/0]
2. Provide annual influenza vaccination 
on-site.
Enhance access to vaccinations, in com-
bination with intervention to increase 
community demand
Annual vaccination for adults aged 50 
and older [//8]
3. Offer a workplace physical activity 
program.
Individually adapted health behavior 
change to increase physical activity
 
Tracking . Survey employees’ health behaviors 
to track effectiveness of health promotion 
efforts.
NA
Communication 5. Conduct targeted health promo-
tion campaigns, focusing on key health 
behaviors and use of preventive health 
care.
Multicomponent interventions to increase 
vaccination; small media to increase 
screening for breast, cervical, and 
colorectal cancers; and one-one educa-
tion to increase breast and cervical can-
cer screening
 
USPSTF indicates United States Preventive Services Task Force; CPB, clinically preventable burden; CE, cost effectiveness; NA, not applicable. 
a Summary of recommendations from the USPSTF (5) and the Community Guide (7), as well as health impact and cost-effectiveness scores from the 
Prevention Priorities (9). 
b Possible scores for both CPB and CE range from  to 5, with 5 indicating greatest value. Scores in this column as cited in Maciosek et al (8). Empty cells 
in this column indicate practices that are not recommended by ACIP or USPSTF. 
Table 2. Employer Characteristics and Chronic Disease Prevention Best Practice Implementation Scoresa at Baseline and 
Follow-Up, 8 Pacific Northwest Employers, American Cancer Society Workplace Solutions Pilot Study, 2005–2006 
Employer Industry
Number of 
Employees  Baseline Score, % Follow-Up Score, %
Change From 
Baseline Score, %
1 Financial 5,000 3 85 2
2 Retail Trade ,72 58 58 0
3 Government 3,000 2 59 7
4 Agriculture 7,500 33 5 23
5 Manufacturing 8,70 27 75 8
6 Government 5,522 37 52 5
7 Retail Trade 5,000 23 37 
8 Manufacturing 2,390 39 7 32
 
a Calculated by adding the scores for all best practices and then dividing by the total number of best practices ( was the denominator for employers with-
out outdoor workers, because best practice 0 [promote sun protection] was not applicable to them; 5 was the denominator for employers with outdoor 
workers). 
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Table 1. (continued) Employers’ Best Practices for Preventing Chronic Diseases, by Practice Type, 8 Pacific Northwest 
Employers, American Cancer Society Workplace Solutions Pilot Study, 2005–2006Table 3. Meana Scores for Implementation of Best Practices to Prevent Chronic Diseases at Baseline and Follow-Up, 8 Pacific 
Northwest Employers, American Cancer Society Workplace Solutions Pilot Study, 2005–2006 
Best Practiceb
Mean Score at 
Baseline, % 
(95% CI)
Mean Score at 
Follow-up, % 
(95% CI)
Mean Change in 
Score, % (Range) P Valuec
. Cover tobacco cessation treatment 35 (-5)  (35-97) 3 (0-75) .03
2. Cover recommended cancer screenings 78 (7-8) 9 (88-00) 8 (0-25) .03
3. Cover influenza vaccination 9 (-93) 88 (7-99) 9 (0-00) .25
. Send preventive services reminders 0 38 (0-8) 38 (0-00) .25
5. Track delivery of preventive services 0 50 (0-95) 50 (0-00) .3
. Have a tobacco ban 72 (-98) 72 (-98) 0 >.99
7. Have “Use the stairs” signs 3 (0-2) 25 (0-) 2 (0-00) >.99
8. Provide physical activity facilities 3 (28-97) 7 (39-00) 8 (0-33) .50
9. Provide healthy food choices 3 (0-2) 50 (-89) 9 (0-00) .3
0. Promote sun protection 0 0 0 NA
. Have a tobacco cessation quit-line 25 (0-) 3 (9-00) 38 (0-00) .25
2. Provide on-site influenza vaccination 3 (29-9) 8 (52-00) 8 (0-00) .25
3. Have physical activity programs 25 (0-) 3 (9-00) 38 (0-00) .25
. Track employee health behaviors 25 (0-) 50 (5 -95) 25 (0-00) .50
5. Use health promotion campaigns 30 (5-55) 50 (23-77) 20 (0-00) .22
Total best practice scored 38 (29-7)  (9-7) 23 (0-8) .02
 
NA indicates not applicable. 
a Means rather than medians are presented for ease of interpretation of change in scores from baseline to follow-up. 
b Best practices scored from 0 to .00. 
c P values (α = .05) derived from 2-tailed nonparametric sign tests. 
d Calculated by adding the scores for all best practices and then dividing by the total number of best practices ( was the denominator for employers with-
out outdoor workers, because best practice 0 [promote sun protection] was not applicable to them; 5 was the denominator for employers with outdoor 
workers).
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